SXTP
HEALTHCARE60 Degrees Pharmaceuticals Inc
$1.66+0.01 (+0.61%)PRE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving SXTP Today?
No stock-specific AI insight has been generated for SXTP yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$1.29$14.68
$1.66
Fundamentals
Market Cap$4M
P/E Ratio—
EPS$-11.73
Dividend Yield—
Dividend / Share—
ROE-2.0%
Profit Margin—
Debt / Equity—
Trading
Volume44K
Avg Volume (10D)—
Shares Outstanding2.6M
SXTP News
20 articles- RedChip's Biotech Investor Conference Replays Now AvailableYahoo Finance·Apr 20, 2026
- 60 Degrees Pharma Announces ARAKODA (tafenoquine) for Malaria Prevention is Now Available on Runway Health Travel WebsiteYahoo Finance·Apr 15, 2026
- 60 Degrees Pharmaceuticals Inc. (SXTP) Upgraded to Buy: Here's What You Should KnowYahoo Finance·Apr 3, 2026
- Infrastructure Capital and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TVYahoo Finance·Apr 2, 2026
- RedChip Showcases Public Companies Driving Biotech Innovation at April 16 Virtual Investor ConferenceYahoo Finance·Apr 2, 2026
- 60 Degrees Pharmaceuticals Announces 2025 Annual ResultsYahoo Finance·Mar 31, 2026
- 60 Degrees Pharmaceuticals Files New Dietary Ingredient Notification (NDIN) with FDA for Australian Chestnut ExtractYahoo Finance·Mar 18, 2026
- 60 Degrees Pharmaceuticals Announces All Patients Cured of Babesiosis After Tafenoquine Treatment in Expanded Use Clinical TrialYahoo Finance·Mar 11, 2026
- 60 Degrees Pharmaceuticals and BioVie Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TVYahoo Finance·Feb 27, 2026
- 60 Degrees Pharmaceuticals (SXTP) Partners With GoodRx to Expand Access to ARAKODAYahoo Finance·Feb 24, 2026
- Is GoodRx (GDRX) Using ARAKODA Discounts To Quietly Redefine Its Preventive Care Strategy?Yahoo Finance·Feb 8, 2026
- 60 Degrees Pharmaceuticals Expands Access to ARAKODA® with GoodRx PartnershipYahoo Finance·Feb 2, 2026
- 60 Degrees Pharmaceuticals Exercises License Option with Florida State University for Large-Scale Purification of Castanospermine for Non-Rx UseYahoo Finance·Jan 28, 2026
- Sector Update: Health Care Stocks Mixed Late AfternoonYahoo Finance·Jan 22, 2026
- Top Midday GainersYahoo Finance·Jan 22, 2026
- Sector Update: Health Care Stocks Rise in Afternoon TradingYahoo Finance·Jan 22, 2026
- Wall Street Set to Open Higher Thursday as Investors Parse GDP, Unemployment Data, Look Ahead to Inflation ReportYahoo Finance·Jan 22, 2026
- Investors Await Raft of Key Economic Data as US Futures Rise Thursday Pre-BellYahoo Finance·Jan 22, 2026
- 60 Degrees Pharmaceuticals Announces Partnership with Runway Health to Provide International Travelers Direct Access to ARAKODA® for Malaria PreventionYahoo Finance·Jan 22, 2026
- 60 Degrees Pharmaceuticals, Inc. Announces Approval of Reverse Stock Split RatioYahoo Finance·Jan 15, 2026
All 20 articles loaded
Price Data
Open$1.60
Previous Close$1.65
Day High$1.65
Day Low$1.55
52 Week High$14.68
52 Week Low$1.29
52-Week Range
$1.29$14.68
$1.66
Fundamentals
Market Cap$4M
P/E Ratio—
EPS$-11.73
Dividend Yield—
Dividend / Share—
ROE-2.0%
Profit Margin—
Debt / Equity—
Trading
Volume44K
Avg Volume (10D)—
Shares Outstanding2.6M
About 60 Degrees Pharmaceuticals Inc
60 Degrees Pharmaceuticals, Inc. is a specialty pharmaceutical company that engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases. The company is headquartered in Washington, District of Columbia.
HEALTHCAREBIOTECHNOLOGY
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICBIOTECHNOLOGY
CIK—
Composite FIGI—
Share Class FIGI—